Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 2/2012

01.04.2012 | Headache (I Garza, Section Editor)

Recent Advances in Diagnostic Strategies for Giant Cell Arteritis

verfasst von: Tanaz A. Kermani, Kenneth J. Warrington

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Giant cell arteritis (GCA) is a systemic vasculitis that affects the aorta and its major branches. Involvement of the ciliary artery can result in ischemic optic neuropathy and subsequent blindness, which is typically irreversible. If GCA is suspected, treatment with glucocorticoids should be initiated promptly to prevent further vision loss. However, given the need for prolonged therapy with glucocorticoids and the morbidity associated with their use, diagnosis should be confirmed. Clinical features and laboratory findings are neither sensitive nor specific for GCA. The mainstay of diagnosis remains histopathologic examination of a section of the superficial temporal artery. Several imaging studies have been used to evaluate the temporal artery but, at present, their utility as alternatives to a temporal artery biopsy is limited. Recent advances in imaging modalities have allowed detailed noninvasive imaging of the large arteries and are a useful adjunct for the diagnosis of GCA, particularly in patients with primarily large-vessel involvement in whom temporal artery biopsy is often negative.
Literatur
1.
Zurück zum Zitat •• Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-45. This is an excellent general review of GCA and polymyalgia rheumatica, a related condition. PubMedCrossRef •• Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-45. This is an excellent general review of GCA and polymyalgia rheumatica, a related condition. PubMedCrossRef
2.
Zurück zum Zitat Kermani TA, Schafer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780–1.PubMedCrossRef Kermani TA, Schafer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780–1.PubMedCrossRef
3.
Zurück zum Zitat •• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al.: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–61. This is a literature review of the epidemiology of GCA and the geographic differences in incidence. PubMedCrossRef •• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al.: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–61. This is a literature review of the epidemiology of GCA and the geographic differences in incidence. PubMedCrossRef
4.
Zurück zum Zitat • Crowson CS, Matteson EL, Myasoedova E, et al.: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9. Using population-based incidence cohorts of several rheumatic diseases, estimates of the lifetime risk of autoimmune conditions in adults in the United States are provided. PubMedCrossRef • Crowson CS, Matteson EL, Myasoedova E, et al.: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9. Using population-based incidence cohorts of several rheumatic diseases, estimates of the lifetime risk of autoimmune conditions in adults in the United States are provided. PubMedCrossRef
5.
Zurück zum Zitat Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–5.PubMed Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–5.PubMed
6.
Zurück zum Zitat Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293–7.PubMedCrossRef Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293–7.PubMedCrossRef
7.
Zurück zum Zitat Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283–92.CrossRef Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283–92.CrossRef
8.
Zurück zum Zitat Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.PubMedCrossRef Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.PubMedCrossRef
9.
Zurück zum Zitat • Kermani TA, Matteson EL, Hunder GG, Warrington KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. The Journal of rheumatology. 2009;36:2277–83. This is the largest clinical series of the features and prognosis of symptomatic lower extremity vasculitis, a rare and likely under-recognized complication from GCA. PubMedCrossRef • Kermani TA, Matteson EL, Hunder GG, Warrington KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. The Journal of rheumatology. 2009;36:2277–83. This is the largest clinical series of the features and prognosis of symptomatic lower extremity vasculitis, a rare and likely under-recognized complication from GCA. PubMedCrossRef
10.
Zurück zum Zitat Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532–7.PubMedCrossRef Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532–7.PubMedCrossRef
11.
Zurück zum Zitat Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703–8.PubMedCrossRef Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703–8.PubMedCrossRef
12.
Zurück zum Zitat Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef
13.
Zurück zum Zitat Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.PubMedCrossRef Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.PubMedCrossRef
14.
Zurück zum Zitat Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406–8.CrossRef Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406–8.CrossRef
15.
Zurück zum Zitat Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309–18.PubMed Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309–18.PubMed
16.
Zurück zum Zitat Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.PubMedCrossRef Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.PubMedCrossRef
17.
Zurück zum Zitat • Agard C, Barrier JH, Dupas B, et al.: Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670–6. This is a study highlighting the prevalence of incidentally noted aortic abnormalities using computed tomography in subjects with newly diagnosed GCA. PubMedCrossRef • Agard C, Barrier JH, Dupas B, et al.: Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670–6. This is a study highlighting the prevalence of incidentally noted aortic abnormalities using computed tomography in subjects with newly diagnosed GCA. PubMedCrossRef
18.
Zurück zum Zitat Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356–9.PubMedCrossRef Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356–9.PubMedCrossRef
19.
Zurück zum Zitat Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92–101.PubMedCrossRef Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92–101.PubMedCrossRef
20.
Zurück zum Zitat Younge BR, Cook Jr BE, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483–91.PubMedCrossRef Younge BR, Cook Jr BE, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483–91.PubMedCrossRef
21.
Zurück zum Zitat Walvick MD, Walvick MP. Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery Biopsy. Ophthalmology. 2011;118:1201–4.PubMedCrossRef Walvick MD, Walvick MP. Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery Biopsy. Ophthalmology. 2011;118:1201–4.PubMedCrossRef
22.
Zurück zum Zitat Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667–71.PubMedCrossRef Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667–71.PubMedCrossRef
23.
Zurück zum Zitat Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550–4.PubMedCrossRef Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550–4.PubMedCrossRef
24.
Zurück zum Zitat Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–8.PubMedCrossRef Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–8.PubMedCrossRef
25.
Zurück zum Zitat Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–5.PubMedCrossRef Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–5.PubMedCrossRef
26.
Zurück zum Zitat Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987–92.PubMed Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987–92.PubMed
27.
Zurück zum Zitat Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530–2.PubMedCrossRef Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530–2.PubMedCrossRef
28.
Zurück zum Zitat Salvarani C, Crowson CS, O’Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264–8.PubMedCrossRef Salvarani C, Crowson CS, O’Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264–8.PubMedCrossRef
29.
Zurück zum Zitat Niederkohr RD, Levin LA. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci. 2007;48:675–80.PubMedCrossRef Niederkohr RD, Levin LA. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci. 2007;48:675–80.PubMedCrossRef
30.
Zurück zum Zitat Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32:1279–82.PubMed Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32:1279–82.PubMed
31.
Zurück zum Zitat Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826–8.PubMedCrossRef Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826–8.PubMedCrossRef
32.
Zurück zum Zitat Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10:381–6.PubMed Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10:381–6.PubMed
33.
Zurück zum Zitat Ponge T, Barrier JH, Grolleau JY, et al. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol. 1988;15:997–1000.PubMed Ponge T, Barrier JH, Grolleau JY, et al. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol. 1988;15:997–1000.PubMed
34.
Zurück zum Zitat Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.PubMedCrossRef Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.PubMedCrossRef
35.
Zurück zum Zitat Danesh-Meyer HV, Savino PJ, Eagle Jr RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213–5.PubMedCrossRef Danesh-Meyer HV, Savino PJ, Eagle Jr RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213–5.PubMedCrossRef
36.
Zurück zum Zitat Pless M, Rizzo 3rd JF. Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216–8.PubMedCrossRef Pless M, Rizzo 3rd JF. Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216–8.PubMedCrossRef
37.
Zurück zum Zitat Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009;36:794–6.PubMedCrossRef Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009;36:794–6.PubMedCrossRef
38.
Zurück zum Zitat •• Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Current opinion in rheumatology. 2009;21:19–28. This is a review of PET, MRI, and US for evaluation of patients with GCA by leading experts in this field. PubMedCrossRef •• Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Current opinion in rheumatology. 2009;21:19–28. This is a review of PET, MRI, and US for evaluation of patients with GCA by leading experts in this field. PubMedCrossRef
39.
Zurück zum Zitat Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.PubMedCrossRef Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.PubMedCrossRef
40.
Zurück zum Zitat Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359–69.PubMed Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359–69.PubMed
41.
Zurück zum Zitat Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8:R116.PubMedCrossRef Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8:R116.PubMedCrossRef
42.
Zurück zum Zitat •• Schmidt WA, Seifert A, Gromnica-Ihle E, et al.: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96–101. This study used systematic US of several arterial beds in 176 patients with newly diagnosed GCA and highlights the prevalence of incidentally noted findings of vasculitis in multiple arterial beds in GCA. CrossRef •• Schmidt WA, Seifert A, Gromnica-Ihle E, et al.: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96–101. This study used systematic US of several arterial beds in 176 patients with newly diagnosed GCA and highlights the prevalence of incidentally noted findings of vasculitis in multiple arterial beds in GCA. CrossRef
43.
Zurück zum Zitat Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.PubMedCrossRef Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.PubMedCrossRef
44.
Zurück zum Zitat Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574–8.PubMedCrossRef Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574–8.PubMedCrossRef
45.
Zurück zum Zitat Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000;11:481–7.PubMedCrossRef Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000;11:481–7.PubMedCrossRef
46.
Zurück zum Zitat Kawasaki A, Michel P, Maeder P, Borruat FX. Visualizing the skip lesions of giant cell arteritis with CT arteriography. Eur Neurol. 2009;61:374.PubMedCrossRef Kawasaki A, Michel P, Maeder P, Borruat FX. Visualizing the skip lesions of giant cell arteritis with CT arteriography. Eur Neurol. 2009;61:374.PubMedCrossRef
47.
Zurück zum Zitat Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu’s arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25–32.PubMedCrossRef Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu’s arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25–32.PubMedCrossRef
48.
Zurück zum Zitat Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45:906–14.PubMedCrossRef Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45:906–14.PubMedCrossRef
49.
Zurück zum Zitat Brodmann M, Lipp RW, Passath A, et al. The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241–2.CrossRef Brodmann M, Lipp RW, Passath A, et al. The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241–2.CrossRef
50.
Zurück zum Zitat Lehmann P, Buchtala S, Achajew N, et al. 18 F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol. 2011;30:37–42.PubMedCrossRef Lehmann P, Buchtala S, Achajew N, et al. 18 F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol. 2011;30:37–42.PubMedCrossRef
51.
Zurück zum Zitat •• Besson FL, Parienti JJ, Bienvenu B, et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72. This is a meta-analysis of six controlled studies evaluating the test characteristics of PET for the diagnosis of GCA. PubMedCrossRef •• Besson FL, Parienti JJ, Bienvenu B, et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72. This is a meta-analysis of six controlled studies evaluating the test characteristics of PET for the diagnosis of GCA. PubMedCrossRef
Metadaten
Titel
Recent Advances in Diagnostic Strategies for Giant Cell Arteritis
verfasst von
Tanaz A. Kermani
Kenneth J. Warrington
Publikationsdatum
01.04.2012
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 2/2012
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-011-0243-6

Weitere Artikel der Ausgabe 2/2012

Current Neurology and Neuroscience Reports 2/2012 Zur Ausgabe

Pediatric Neurology (R Packer, Section Editor)

Narcolepsy in the Pediatric Population

Headache (I Garza, Section Editor)

Nummular Headache Update

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.